Dose Adjustment for Normal Eating (DAFNE) in routine clinical practice: who benefits?

A J A Keen, E Duncan, A McKillop-Smith, N D Evans, A E Gold

Research output: Contribution to journalArticlepeer-review

18 Citations (Scopus)

Abstract

Aims To explore the effectiveness of Dose Adjustment for Normal Eating in routine clinical practice in the UK. Methods Participants were 124 adults with Type 1 diabetes who had completed a Dose Adjustment for Normal Eating course. Data were collected before the course and again 1 year later on a variety of biological, psychological and social measures. Results There were a range of significant benefits consistent with Dose Adjustment for Normal Eating aims, including: better control among those with baseline HbA(1c) = 81 mmol/mol (9.6%) (z = -2.8, P = 0.004); reduced number of participants reporting severe hypoglycaemia (¿² = 4.27, P = 0.039); total eradication of diabetic ketoacidosis (¿² = 4.17, P = 0.041) and lower diabetes-related distress (z = -4.5, P
Original languageEnglish
Pages (from-to)670-676
Number of pages6
JournalDiabetic Medicine
Volume29
Issue number5
Early online date16 Apr 2012
DOIs
Publication statusPublished - May 2012

Keywords

  • education
  • patient education
  • Type 1 diabetes

Fingerprint Dive into the research topics of 'Dose Adjustment for Normal Eating (DAFNE) in routine clinical practice: who benefits?'. Together they form a unique fingerprint.

Cite this